nitrofurantoin has been researched along with minocycline in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (7.41) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (29.63) | 29.6817 |
2010's | 15 (55.56) | 24.3611 |
2020's | 2 (7.41) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Kornguth, ML; Kunin, CM; Monson, RA | 1 |
Krech, U; Price, P; Schmid, E | 1 |
Cunha, BA | 1 |
Garau, J | 1 |
Fux, R; Gleiter, CH; Mörike, K | 1 |
Björnsson, E; Kamath, PS; Lindor, K; Neuhauser, M; Sanderson, S; Takahashi, N; Talwalkar, J; Treeprasertsuk, S | 1 |
Efe, C; Ozaslan, E; Purnak, T; Wahlin, S | 1 |
Czaja, AJ | 1 |
Andrade, RJ; Castiella, A; Lucena, MI; Otazua, P; Zapata, EM | 1 |
Bernard-Chabert, B; Diebold, MD; Heurgué-Berlot, A; Thiéfin, G | 1 |
Ito, T; Shiraki, K; Sugimoto, K; Yamamoto, N | 1 |
Al-Nassay, F; Al-Zarooni, N; Al-Zarouni, M; Panigrahi, D; Senok, A | 1 |
Ahrens, W; Bonkovsky, HL; deLemos, AS; Foureau, DM; Jacobs, C; Russo, MW | 1 |
Erayman, B; Koroglu, M; Salvarci, A | 1 |
Bader, MS; Brooks, AA; Loeb, M | 1 |
Andrade, RJ; Björnsson, ES; Lucena, MI; Medina-Caliz, I | 1 |
Aladawi, M; Dyck, PJB; Engelstad, J; Koster, M; Naddaf, E; Piccione, EA; Shelly, S | 1 |
7 review(s) available for nitrofurantoin and minocycline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
New uses for older antibiotics: nitrofurantoin, amikacin, colistin, polymyxin B, doxycycline, and minocycline revisited.
Topics: Amikacin; Cell Membrane; Colistin; Doxycycline; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Methicillin Resistance; Minocycline; Nitrofurantoin; Polymyxin B; Staphylococcal Infections; Urinary Tract Infections | 2006 |
Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Fosfomycin; Microbial Sensitivity Tests; Minocycline; Nitrofurantoin; Tigecycline | 2008 |
Drug-induced autoimmune-like hepatitis.
Topics: Adrenal Cortex Hormones; Anti-Infective Agents; Autoantibodies; Chemical and Drug Induced Liver Injury; Female; Hepatitis, Autoimmune; HLA Antigens; Humans; Immune Tolerance; Male; Minocycline; Nitrofurantoin; Oxidative Stress; Polymorphism, Genetic; Risk Factors; Sex Factors; Treatment Outcome | 2011 |
Drug-induced liver injury with autoimmune features.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Antihypertensive Agents; Autoantibodies; Autoimmunity; Chemical and Drug Induced Liver Injury; Cytokines; Diagnosis, Differential; Drug Hypersensitivity; Female; Hepatitis, Autoimmune; HLA Antigens; Humans; Hydralazine; Hypergammaglobulinemia; Liver; Liver Function Tests; Male; Methyldopa; Minocycline; Nitrofurantoin; Time Factors; Young Adult | 2014 |
An update on the management of urinary tract infections in the era of antimicrobial resistance.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Comorbidity; Drug Resistance, Bacterial; Fluoroquinolones; Fosfomycin; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Minocycline; Nitrofurantoin; Severity of Illness Index; Urinary Tract Infections | 2017 |
Nitrofurantoin and Minocycline-Associated Vasculitic Neuropathy: Case Reports and Literature Review.
Topics: Adult; Female; Humans; Middle Aged; Minocycline; Nitrofurantoin; Peripheral Nervous System Diseases; Peroneal Neuropathies; Vasculitis; Young Adult | 2022 |
20 other study(ies) available for nitrofurantoin and minocycline
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Binding of antibiotics to a soluble protein from rat liver.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Carbon Radioisotopes; Cephalexin; Cephalothin; Chloramphenicol; Chromatography, Gel; Chromatography, Ion Exchange; Erythromycin; Lincomycin; Liver; Liver Extracts; Male; Minocycline; Nitrofurantoin; Penicillin G; Polymyxins; Protein Binding; Rats; Tetracycline | 1974 |
[Sensitivity range of gram-negative microorganisms and mycoplasms to minocycline in vitro].
Topics: Acholeplasma laidlawii; Ampicillin; Bacteria; Carbenicillin; Cephalothin; Chloramphenicol; Escherichia; Gentamicins; Klebsiella; Microbial Sensitivity Tests; Minocycline; Mycoplasma; Nalidixic Acid; Nitrofurantoin; Polymyxins; Proteus; Proteus mirabilis; Pseudomonas; Salmonella; Sulfamethoxazole; Tetracycline; Trimethoprim | 1974 |
[Unwanted side effects of antibacterials--a diagnostic challenge].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Aza Compounds; Dementia; Female; Fluoroquinolones; Humans; Male; Middle Aged; Minocycline; Moxifloxacin; Nitrofurantoin; Pseudotumor Cerebri; Pulmonary Fibrosis; Quinolines; Young Adult | 2008 |
Drug-induced autoimmune hepatitis: clinical characteristics and prognosis.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Female; Hepatitis, Autoimmune; Humans; Male; Middle Aged; Minocycline; Nitrofurantoin; Prognosis; United States; Young Adult | 2010 |
Drug-induced autoimmune hepatitis caused by anti-tumor necrosis factor α agents.
Topics: Clinical Enzyme Tests; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver; Minocycline; Nitrofurantoin; Tumor Necrosis Factor-alpha | 2010 |
Drug-induced autoimmune-like hepatitis: a diagnostic challenge.
Topics: Anti-Infective Agents; Female; Hepatitis, Autoimmune; Humans; Male; Minocycline; Nitrofurantoin | 2011 |
Drug-induced autoimmune-like hepatitis: a case of chronic course after drug withdrawal.
Topics: Anti-Infective Agents; Female; Hepatitis, Autoimmune; Humans; Male; Minocycline; Nitrofurantoin | 2011 |
Seven cases of autoimmune hepatitis that developed after drug-induced liver injury.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Female; Hepatitis, Autoimmune; Humans; Male; Minocycline; Nitrofurantoin | 2011 |
Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactam Resistance; Chi-Square Distribution; Enterobacteriaceae; Enterobacteriaceae Infections; Fosfomycin; Genotype; Humans; Minocycline; Nitrofurantoin; Tigecycline; United Arab Emirates; Urinary Tract Infections | 2012 |
Investigation of Antibacterial Activity and Biofilm Formation of Silicones Coated With Minocycline-Rifampicin, Silver Nitrate, and Nitrofurantoin for Short-term Utilization in In Vitro Urinary System Models.
Topics: Anti-Bacterial Agents; Anti-Infective Agents, Local; Biofilms; Coated Materials, Biocompatible; Minocycline; Models, Biological; Nitrofurantoin; Rifampin; Silicones; Silver Nitrate; Time Factors; Urinary Catheterization; Urinary Tract | 2016 |
Setting up criteria for drug-induced autoimmune-like hepatitis through a systematic analysis of published reports.
Topics: Adalimumab; Chemical and Drug Induced Liver Injury; Diclofenac; Female; Hepatitis A; Hepatitis, Autoimmune; Humans; Imatinib Mesylate; Infliximab; Interferons; Methyldopa; Methylprednisolone; Minocycline; Nitrofurantoin | 2022 |